High frequency of WNT-activated medulloblastomas with CTNNB1 wild type suggests a higher proportion of hereditary cases in a Latin-Iberian population.

Saved in:
Bibliographic Details
Title: High frequency of WNT-activated medulloblastomas with CTNNB1 wild type suggests a higher proportion of hereditary cases in a Latin-Iberian population.
Authors: Moreno DA; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil., Bonatelli M; Molecular Diagnosis Laboratory, Barretos Cancer Hospital, Barretos, Brazil., Antoniazzi AP; Cancer Genetics Department, Barretos Cancer Hospital, Barretos, Brazil., de Paula FE; Molecular Diagnosis Laboratory, Barretos Cancer Hospital, Barretos, Brazil., Leal LF; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil.; Pathology Department, Barretos Cancer Hospital, Barretos, Brazil., Garcia FAO; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil., de Paula AE; Molecular Diagnosis Laboratory, Barretos Cancer Hospital, Barretos, Brazil., Teixeira GR; Barretos School of Health Sciences Dr. Paulo Prata, Barretos Cancer Hospital, Barretos, Brazil.; Pathology Department, Barretos Cancer Hospital, Barretos, Brazil., Santana IVV; Barretos School of Health Sciences Dr. Paulo Prata, Barretos Cancer Hospital, Barretos, Brazil., Saggioro F; Department of Pathology and Forensic Medicine, University of São Paulo, Ribeirão Preto, Brazil., Neder L; Department of Pathology and Forensic Medicine, University of São Paulo, Ribeirão Preto, Brazil., Valera ET; Department of Pediatrics of Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil., Scrideli CA; Department of Pediatrics of Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil., Stavale J; Department of Neurology and Neurosurgery, Federal University of São Paulo (UNIFESP), São Paulo, Brazil., Malheiros SMF; Department of Neurology and Neurosurgery, Federal University of São Paulo (UNIFESP), São Paulo, Brazil., Lima M; Oncology Department, AC Camargo Hospital, São Paulo, Brazil., Hajj GNM; Oncology Department, AC Camargo Hospital, São Paulo, Brazil., Garcia-Rivello H; Pathology Department, Italian Hospital of Buenos Aires, Buenos Aires, Argentina., Christiansen S; Pathology Department, Italian Hospital of Buenos Aires, Buenos Aires, Argentina., Nunes S; Pediatric Oncology Department, Centro Hospitalar Universitário São João, Porto, Portugal., Gil-da-Costa MJ; Pediatric Oncology Department, Centro Hospitalar Universitário São João, Porto, Portugal., Pinheiro J; Department of Pathology, Centro Hospitalar Universitário São João, Porto, Portugal., Martins FD; Brasília Children's Hospital, Brasília, Brazil., Junior CA; Pediatric Neurosurgery Department, Barretos Cancer Hospital, Barretos, Brazil., Mançano BM; Pediatric Oncology Department, Barretos Cancer Hospital, Barretos, Brazil., Reis RM; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil.; Molecular Diagnosis Laboratory, Barretos Cancer Hospital, Barretos, Brazil.; ICVS/3B's - PT Government Associate Laboratory, Braga/Guimarães, Portugal.; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.
Source: Frontiers in oncology [Front Oncol] 2023 Sep 04; Vol. 13, pp. 1237170. Date of Electronic Publication: 2023 Sep 04 (Print Publication: 2023).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2234-943X
DOI:10.3389/fonc.2023.1237170